These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33072759)

  • 1. Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting.
    Lopes C; Tang Y; Anjo SI; Manadas B; Onofre I; de Almeida LP; Daley GQ; Schlaeger TM; Rego ACC
    Front Cell Dev Biol; 2020; 8():576592. PubMed ID: 33072759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.
    Xu X; Tay Y; Sim B; Yoon SI; Huang Y; Ooi J; Utami KH; Ziaei A; Ng B; Radulescu C; Low D; Ng AYJ; Loh M; Venkatesh B; Ginhoux F; Augustine GJ; Pouladi MA
    Stem Cell Reports; 2017 Mar; 8(3):619-633. PubMed ID: 28238795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.
    Naia L; Cunha-Oliveira T; Rodrigues J; Rosenstock TR; Oliveira A; Ribeiro M; Carmo C; Oliveira-Sousa SI; Duarte AI; Hayden MR; Rego AC
    J Neurosci; 2017 Mar; 37(10):2776-2794. PubMed ID: 28123081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for
    Szlachcic WJ; Wiatr K; Trzeciak M; Figlerowicz M; Figiel M
    Front Mol Neurosci; 2017; 10():253. PubMed ID: 28848389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.
    Liu Y; Qiao F; Leiferman PC; Ross A; Schlenker EH; Wang H
    Hum Mol Genet; 2017 Nov; 26(22):4416-4428. PubMed ID: 28973411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.
    Joshi AU; Ebert AE; Haileselassie B; Mochly-Rosen D
    J Mol Cell Cardiol; 2019 Feb; 127():125-133. PubMed ID: 30550751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities.
    Malankhanova T; Suldina L; Grigor'eva E; Medvedev S; Minina J; Morozova K; Kiseleva E; Zakian S; Malakhova A
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33182269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.
    Wiatr K; Szlachcic WJ; Trzeciak M; Figlerowicz M; Figiel M
    Mol Neurobiol; 2018 Apr; 55(4):3351-3371. PubMed ID: 28497201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Mitochondrial Function in Human Huntington Disease Lymphoblasts is Not Due to Alterations in Cardiolipin Metabolism or Mitochondrial Supercomplex Assembly.
    Mejia EM; Chau S; Sparagna GC; Sipione S; Hatch GM
    Lipids; 2016 May; 51(5):561-9. PubMed ID: 26846325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
    Seong IS; Ivanova E; Lee JM; Choo YS; Fossale E; Anderson M; Gusella JF; Laramie JM; Myers RH; Lesort M; MacDonald ME
    Hum Mol Genet; 2005 Oct; 14(19):2871-80. PubMed ID: 16115812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
    Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
    Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioenergetic dysfunction in Huntington's disease human cybrids.
    Ferreira IL; Cunha-Oliveira T; Nascimento MV; Ribeiro M; Proença MT; Januário C; Oliveira CR; Rego AC
    Exp Neurol; 2011 Sep; 231(1):127-34. PubMed ID: 21684277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity.
    Mattis VB; Tom C; Akimov S; Saeedian J; Østergaard ME; Southwell AL; Doty CN; Ornelas L; Sahabian A; Lenaeus L; Mandefro B; Sareen D; Arjomand J; Hayden MR; Ross CA; Svendsen CN
    Hum Mol Genet; 2015 Jun; 24(11):3257-71. PubMed ID: 25740845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
    Aladdin A; Király R; Boto P; Regdon Z; Tar K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant huntingtin inhibits the mitochondrial unfolded protein response by impairing ABCB10 mRNA stability.
    Fu Z; Liu F; Liu C; Jin B; Jiang Y; Tang M; Qi X; Guo X
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1428-1435. PubMed ID: 30802639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.
    Naia L; Ribeiro M; Rodrigues J; Duarte AI; Lopes C; Rosenstock TR; Hayden MR; Rego AC
    Neuropeptides; 2016 Aug; 58():73-81. PubMed ID: 26876526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's Disease and Mitochondria.
    Jodeiri Farshbaf M; Ghaedi K
    Neurotox Res; 2017 Oct; 32(3):518-529. PubMed ID: 28639241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
    Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
    Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.